Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represents OMX in the creation of the world’s foremost securities exchange and technology company
Mandate

Vinge represents OMX in the creation of the world’s foremost securities exchange and technology company

May 29, 2007

Vinge is representing OMX in the recommended merger between OMX and NASDAQ that was announced today. This merger will be implemented through a public offer to purchase all the shares of OMX in return for cash and shares of NASDAQ. The offer is based on an evaluation of OMX at SEK 25.1 billion.

Vinge’s team includes Göran Nyström, Erik Sjöman, Maria-Pia Midenbäck, Dain Nevonen, Dan Hanqvist, Johan Karlsson, Kanja Berg, Christian Lindhé, Mattias Schömer and Maria Schultzberg.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024